Financial statements Ferrosan Medical Devices
Cash flow statement of Ferrosan Medical Devices
Company age:
Age:
13 y. 8 m. 2 d.
Share capital:
Share capital:
5 000 PLN
Cash inflows of FERROSAN MEDICAL DEVICES
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Net cash from operating expenses | -7 942 618,27 | 5 072 412,17 | 4 139 851,17 | 7 561 418,71 | 5 609 997,22 |
| Net cash flow from investing activities | -734 176,02 | -257 451,22 | -839 919,21 | -1 119 757,59 | -1 015 959,96 |
| Net cash flow from financial activities | 8 202 053,30 | -3 839 409,12 | -4 350 002,84 | -5 907 557,50 | -1 132 043,44 |
| Total net cash flow | -474 740,99 | 975 551,83 | -1 050 070,88 | 534 103,62 | 3 695 993,82 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.